TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM NEW
Total 13F shares
5,339,239
Share change
+3,542,166
Total reported value
$23,246,826
Price per share
$4.40
Number of holders
23
Value change
+$14,903,959
Number of buys
16
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q2 2017

As of 30 Jun 2017, TRILLIUM THERAPEUTICS INC - COM NEW was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,339,239 shares. The largest 10 holders included NEA Management Company, LLC, AWM Investment Company, Inc., Cormorant Asset Management, LLC, JANUS HENDERSON GROUP PLC, Tekla Capital Management LLC, BAKER BROS. ADVISORS LP, New Leaf Venture Partners, L.L.C., Sectoral Asset Management Inc, INTERNATIONAL BIOTECHNOLOGY TRUST PLC, and VICTORY CAPITAL MANAGEMENT INC. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.